Skip to main content
Trials
Sponsors
Conditions
Drugs
Pricing
Trials
Sponsors
Conditions
Drugs
Pricing
Loading search results
Clinical Trials for "You Zhang, PhD"
6
trials
Share
Relevance
ID
Status
Phase
Title
Sponsor
NCT07794202
Not Yet Recruiting
Not Applicable
Clinical Efficacy Study of Magnesium-Containing Degradable Polymer Bone Repair Material for Bone-Defect Repair After Extremity Bone Tumor Resection
Yu Zhang, PhD
ClinicalTrials.gov
NCT07794202
Not Yet Recruiting
Not Applicable
Clinical Efficacy Study of Magnesium-Containing Degradable Polymer Bone Repair M...
Yu Zhang, PhD
NCT04467801
Unknown
Phase 2
Ipatasertib and Docetaxel in Metastatic NSCLC Patients Who Have Failed 1st Line Immunotherapy
Jun Zhang, MD, PhD
ClinicalTrials.gov
NCT04467801
Unknown
Phase 2
Ipatasertib and Docetaxel in Metastatic NSCLC Patients Who Have Failed 1st Line...
Jun Zhang, MD, PhD
NCT04636775
Unknown
Microbiome in Immunotherapy naïve NSCLC Patients Receiving PD-1/L1 Blockade (MIP_NSCLC)
Jun Zhang, MD, PhD
ClinicalTrials.gov
NCT04636775
Unknown
-
Microbiome in Immunotherapy naïve NSCLC Patients Receiving PD-1/L1 Blockade (MIP...
Jun Zhang, MD, PhD
NCT04680377
Recruiting
Using Microbiome to Predict Durvalumab Toxicity in Post- Concurrent Chemoradiation Therapy (CCRT) NSCLC Patients
Jun Zhang, MD, PhD
ClinicalTrials.gov
NCT04680377
Recruiting
-
Using Microbiome to Predict Durvalumab Toxicity in Post- Concurrent Chemoradiati...
Jun Zhang, MD, PhD
NCT05332925
Recruiting
Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC
Jun Zhang, MD, PhD
ClinicalTrials.gov
NCT05332925
Recruiting
-
Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC
Jun Zhang, MD, PhD
NCT05859217
Not Yet Recruiting
Phase 2
A Study of Combining Cabozantinib and Atezolizumab for Advanced/Metastatic NSCLC (Cabatezo-1)
Exelixis
ClinicalTrials.gov
NCT05859217
Not Yet Recruiting
Phase 2
A Study of Combining Cabozantinib and Atezolizumab for Advanced/Metastatic NSCLC...
Exelixis
Result Breakdown
Status
Not yet recruiting
2 (33%)
Unknown
2 (33%)
Recruiting
2 (33%)
Phase
Not Specified
3 (50%)
Phase 2
2 (33%)
not_applicable
1 (17%)
Top Conditions
NSCLC Stage IV
4 (67%)
Lung Cancer
2 (33%)
Bone Defect
1 (17%)
Show 7 more
Top Sponsors
Jun Zhang, MD, PhD
5 (83%)
Yu Zhang, PhD
1 (17%)
University of Iowa
1 (17%)
Show 5 more
Start your search
Search over 500,000 clinical trials worldwide
Search
Expert
Popular:
Cancer
Diabetes
Alzheimer
COVID-19
Heart Disease